2. Academic Validation
  3. Editorial: Advances in molecular and pharmacological mechanisms of novel targeted therapies for melanoma

Editorial: Advances in molecular and pharmacological mechanisms of novel targeted therapies for melanoma

  • Front Oncol. 2024 Apr 4:14:1403778. doi: 10.3389/fonc.2024.1403778.
Marcel Henrique Marcondes Sari # 1,  Luana Mota Ferreira # 2
Affiliations

Affiliations

  • 1 Departamento de Análises Clínicas, Universidade Federal do Paraná, Curitiba, Paraná, Brazil.
  • 2 Programa de Pós-Graduação em Ciências Farmacêuticas, Universidade Federal do Paraná, Curitiba, Paraná, Brazil.
  • # Contributed equally.
PMID: 38638856 DOI: 10.3389/fonc.2024.1403778
Keywords

cancer biomarkers; drug repositioning; immunology; immunotherapy; melanoma; nanotechnology; skin cancer.

Figures
Products
  • Cat. No.
    Product Name
    Description
    Target
    Research Area
  • HY-132844
    99.53%, MEK1/2 Inhibitor
    MEK